Skip to main content
FinSpry Logo
FinSpry
INSM logo
INSM
(NASDAQ)
Insmed Incorporated
$107.41-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Insmed Incorporated (INSM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Insmed Incorporated stock.

Analyst Consensus Rating

Investment consensus from 20 professional research analysts

Consensus Rating

Buy
Based on 20 unique analysts
(25 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$189.84
↑ 76.74% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest INSM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Eliana Merle
Barclays
BuyMaintains
$237.00
Vamil Divan
Guggenheim
BuyReiterates
$226.00 → $207.00
Faisal Khurshid
Jefferies
BuyMaintains
$175.00
Leonid Timashev
RBC Capital
BuyMaintains
$195.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$212.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$212.00
Ritu Baral
TD Cowen
BuyMaintains
$243.00
Graig Suvannavejh
Mizuho
BuyMaintains
$202.00 → $192.00
Jason Zemansky
BofA Securities
BuyMaintains
$214.00
Olivia Brayer
Cantor Fitzgerald
BuyMaintains
$235.00
Adam Walsh
Roth MKM
BuyMaintains
$212.00
Jessica Fye
JP Morgan
BuyReiterates
$180.00 → $179.00
PerPlexity Biotechnology
TipRanks - PerPlexity
HoldReiterates
$119.00 → $94.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$114.00 → $96.00
Leonid Timashev
RBC Capital
BuyMaintains
$205.00 → $195.00
Ashwani Verma
UBS
BuyReiterates
$166.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$160.00
Ashwani Verma
UBS
BuyReiterates
$166.00
Eliana Merle
Barclays
BuyMaintains
$237.00
Matt Phipps
William Blair
BuyMaintains
-
Danielle Brill
Truist
BuyMaintains
$185.00
Stephen Willey
Stifel Nicolaus
BuyMaintains
$208.00 → $200.00
Andrew Fein
HC Wainwright
BuyMaintains
$220.00
Tiago Fauth
Raymond James
BuyMaintains
$200.00 → $185.00
Vamil Divan
Guggenheim
BuyReiterates
$230.00 → $226.00

Frequently Asked Questions

What is the analyst consensus rating for INSM?

The analyst consensus rating for INSM is "Buy" based on 20 analyst recommendations.

What is the average price target for INSM?

The average 12-month price target for INSM is $189.84, representing an upside of 76.7% from the current price of $107.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.